ANA CATHARINA DE SEIXAS SANTOS NASTRI
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/07 - Laboratório de Gastroenterologia Clínica e Experimental, Hospital das Clínicas, Faculdade de Medicina
LIM/07 - Laboratório de Gastroenterologia Clínica e Experimental, Hospital das Clínicas, Faculdade de Medicina
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
- Sabia Virus-Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020(2020) MALTA, Fernanda de Mello; AMGARTEN, Deyvid; NASTRI, Ana Catharina de Seixas Santos; HO, Yeh-Li; CASADIO, Luciana Vilas Boas; BASQUEIRA, Marcela; SELEGATTO, Gloria; CERVATO, Murilo Castro; DUARTE-NETO, Amaro Nunes; HIGASHINO, Hermes Ryoiti; MEDEIROS, Felipe Arthur Faustino; GENDLER, Jose Luiz Pinto Lima; LEVIN, Anna S.; PINHO, Joao Renato RebelloNew World arenaviruses can cause chronic infection in rodents and hemorrhagic fever in humans. We identified a Sable virus-like mammarenevirus in a patient with fatal hemorrhagic fever from Sao Paulo, Brazil. The virus was detected through virorne enrichment and metagenomic next-generation sequencing technology.
- Late-Onset Relapsing Hepatitis Associated with Yellow Fever(2020) CASADIO, Luciana; NASTRI, Ana C.Brazil has had 2585 confirmed cases of yellow fever during the past 2 years. In this report, investigators from Sao Paulo describe cases of hepatitis occurring weeks to months after resolution of acute illness with yellow fever.
- Monkeypox Virus Transmission to Healthcare Worker through Needlestick Injury, Brazil(2022) CARVALHO, Laina Bubach; CASADIO, Luciana V. B.; POLLY, Matheus; NASTRI, Ana Catharina; TURDO, Anna Claudia; ELIODORO, Raissa H. De Araujo; SABINO, Ester Cerdeira; LEVIN, Anna Sara; PROENCA, Adriana Coracini Tonacio de; HIGASHINO, Hermes RyoitiWe describe monkeypox virus (MPXV) transmission from a patient to a healthcare worker through needlestick injury. A lesion appeared at the inoculation site 5 days after inju-ry. Blood tested MPXV-positive by PCR before symptoms worsened; blood remained MPXV-positive at discharge 19 days after symptom onset. Postexposure prophylaxis could prevent potential MPXV bloodborne transmission.